Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-[3-oxo-3-[[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]propyl]-4-(trifluoromethoxy)-benzamide | 2029049-79-2 | MFCD30489750 | 99.7% | 406.40 | C21H21F3N2O3 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1006885MG

Encompass_Preferred

ML390 is a small-molecule inhibitor of dihydroorotate dehydrogenase (DHODH) that induces myeloid differentiation in murine and human acute myeloid leukemia (AML) models. It is supplied as a solid research-grade compound for biochemical and cellular studies.

  • Potent DHODH inhibitor that induces myeloid differentiation in AML models.
  • High purity (99.72%) suitable for biochemical and cellular assays.
  • Molecular weight 406.40 and formula C21H21F3N2O3 for accurate dosing and calculations.
  • White to off-white solid appearance, easy to handle and weigh.
  • Stable as a powder at -20°C for up to 3 years and at 4°C for up to 2 years.
  • Available in small research pack sizes including 5 mg for screening and pilot studies.

Catalog No. 50-196-7768


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.